Search
Roughly 6,000 UT Southwestern caregivers receive COVID-19 vaccine: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/caregivers-receive-vaccine.html
Nearly 6,000 front-line health care workers at UT Southwestern have received initial doses of the COVID-19 vaccine since the Medical Center received its first shipment of 5,850 doses on Dec. 15.
Scientists weigh in on debate to quash daylight saving: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/daylight-saving.html
Dr. Joseph Takahashi, who discovered the first circadian gene in mammals (CLOCK), points out that desynchronized body clocks are linked to greater health risks such as obesity, heart attack, cancer, and depression.
Dr. Takahashi receives global award for pioneering work on circadian rhythms: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/takahashi-circadian-rhythms-award.html
Dr. Joseph S. Takahashi has received an international award for his pioneering work on the molecular and genetic bases of circadian rhythms in mammals.
UT Southwestern and Children’s Health receive record-setting gift from Moody Foundation : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/may-pediatrics-campus-gift-moody-foundation.html
UT Southwestern Medical Center and Children’s Health℠ today announced a historic nine-figure grant from the Moody Foundation to support the new $5 billion pediatric campus in Dallas, which broke ground in October 2024. The new hospital will help meet the increasing demand for pediatric health care
Chen, Hooper elected to National Academy of Medicine: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-national-academy-of-medicine.html
The National Academy of Medicine announced the election of two UT Southwestern Medical Center faculty members – Lora Hooper, Ph.D., Chair of Immunology, and Zhijian “James” Chen, Ph.D., Professor of Molecular Biology and Director of the Center for Inflammation Research.
UTSW Medical Student Dean selected for prestigious Piper Professor Award for educators: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/piper-professor-award.html
Dr. Angela Mihalic, Dean of Medical Students and Associate Dean of Student Affairs, has been selected to receive the 2019 Minnie Stevens Piper Foundation’s Piper Professor Award, a prestigious honor that recognizes outstanding college professors across Texas.
UT Southwestern campaign infuses $1B into Peter O’Donnell Jr. Brain Institute : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/obi-philanthropic-campaign.html
UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.
Newsroom Archive: 2023 - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/
Stories published in 2023 about UT Southwestern Medical Center.
Magnetic fields kill bacteria that infect medical implants: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/feb-magnetic-fields-kill-bacteria.html
UT Southwestern Medical Center is collaborating with Pfizer Inc. to develop RNA enhanced delivery technologies for genetic medicine therapies through the Dallas-based medical center’s Program in Genetic Drug Engineering.
Biomarkers linked to side effects from cancer immunotherapy
https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-immunotherapy-biomarkers.html
A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy.